227
active patent families for single-use autoinjectors
With 227 patent families, which is 2.5 times more than our closest competitor, we lead the way in innovation.
Innovation in drug delivery
We shape the future as the innovation leader.
SHL Medical is not only a medical device company; we are an innovation company. Not only did we pioneer the autoinjector market, but we are also pushing the envelope in future drug delivery.
Facts and figures
Innovation comes in many forms at SHL
As the innovation leader and pioneer, we shape the future and reinvent drug
delivery solutions together with our customers.
Product innovation
We are the most trusted brand in pharma and biotech, and we have launched over 50 autoinjector combination products. However, we are not stopping now; we are constantly pushing for new innovative products that will allow even more patients to lead better lives through self-administration and improved treatment experiences.
Manufacturing innovation
A key component of SHL Medical's success lies in its fully vertically integrated approach. This structure enables us to innovate our production processes, as we design and build our own manufacturing and testing equipment to provide optimal support throughout the device development value chain. By handling the majority of processes in-house, we proudly position ourselves as a comprehensive, end-to-end solution provider.
Genuine sustainability
SHL Medical is committed to a truly sustainable approach, addressing environmental responsibility holistically. Rather than engaging in superficial measures, we focus on genuine improvements in our manufacturing processes, implementing innovative changes and continuously pursuing efficiency gains to reduce electricity consumption, minimize manufacturing waste, and more.
Elexy™
SHL Medical's first electromechanical autoinjector is a one-of-kind. It is truly versatile as it features one interface for both pre-filled syringes and cartridges. IIts versatility also accelerates time to market for new drug therapies, helping companies quickly respond to emerging therapeutic needs. Elexy™ offers top-tier flexibility across diverse injection profiles, accommodating varying volumes, viscosities, injection durations, and primary container types, all with reliable performance. Its power unit supports drug cassettes containing either pre-filled syringes (1.0 mL and 2.25 mL) or cartridges (3.0 mL and 5.0 mL).
Molly® Connected Cap
At SHL Medical, envisioning the future of Digital Health is a priority. We are not only developing new connected devices but also actively developing connectivity solutions for existing marketed products. While challenging, innovation remains a hallmark of our work, exemplified by the creation of the Molly® Connected Cap—a compact, retrofittable autoinjector add-on that records and transmits data on patients’ device usage.
Large-volume/high-viscosity drug delivery systems
SHL Medical is currently developing the future landscape of versatile drug delivery systems that support the growing trend toward personalized medicine and less frequent injections. Often developed as large-volume and/or high-viscosity subcutaneous formulations, these novel therapeutic molecules require innovative technologies that consider the delivery mechanism and patients’ ease of use. We are hopeful that our new and innovative product platforms will support self-administration for therapeutic areas like oncology.
